Skip to main content
Pangen Biotech Inc. logo

Pangen Biotech Inc. — Investor Relations & Filings

Ticker · 222110 ISIN · KR7222110009 KO Manufacturing
Open in API
Filings indexed 333 across all filing types
Latest filing 2021-06-29 Legal Proceedings Report
Country KR South Korea
Listing KO 222110

About Pangen Biotech Inc.

https://pangen.com/layout/eng/home.php

Pangen Biotech Inc. is a biotechnology company specializing in the research, development, and manufacturing of biopharmaceuticals. The company utilizes its proprietary platform technologies, particularly those based on Chinese Hamster Ovary (CHO) cell lines, for the production of complex protein therapeutics. Its primary business activities include the development of a pipeline of biosimilar products, such as Erythropoietin (EPO) and Aflibercept. In addition to its own product pipeline, Pangen Biotech offers Contract Development and Manufacturing Organization (CDMO) services, providing expertise in cell line development and biopharmaceutical production to other firms. The company also supplies reagents and kits for research applications.

Recent filings

Filing Released Lang Actions
투자판단관련주요경영사항(A형 혈우병 치료제 PGA40의 다국가 임상3상시험 계획변경 신청)
Legal Proceedings Report Classification · 100% confidence The document is a regulatory filing from the Korean Exchange (KRX) system, specifically a 'Major Management Matter' disclosure regarding a clinical trial plan amendment for a hemophilia treatment (PGA40). Since it details a specific regulatory event (clinical trial application) and does not fit into specialized categories like M&A, dividends, or financial reports, it is classified as a general regulatory filing.
2021-06-29 Korean
[기재정정]최대주주변경을수반하는주식담보제공계약체결
Major Shareholding Notification Classification · 100% confidence The document is a regulatory filing from a Korean company (Pangen) regarding a 'Correction Report' (정정신고) for a 'Pledge of Shares Contract' (주식 담보제공 계약). This type of filing, which details the pledging of shares by a major shareholder as collateral for loans, falls under the category of capital and financing updates, as it relates to the company's capital structure and shareholder obligations. It does not fit into specific categories like 'Director's Dealing' (which is for personal trades) or 'Major Shareholding Notification' (which is for crossing ownership thresholds). Therefore, it is classified as a Capital/Financing Update.
2021-06-21 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership, including special relationships, shareholding ratios, and collateral agreements (pledges). This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema, as it tracks significant changes in ownership thresholds.
2021-06-21 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and specifically a '정정신고' (Amendment Report). It details changes to the number of stock options granted to employees and executives. This type of filing, which relates to capital structure changes and employee compensation via stock options, is classified under 'Regulatory Filings' (RNS) as it is a specific corporate disclosure required by the financial regulator (Financial Services Commission/Korea Exchange) that does not fit into the more specific categories like 'Director's Dealing' or 'Share Issue'.
2021-06-21 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a standard regulatory filing in South Korea (often referred to as a 5% rule filing). It details the acquisition of shares by Huons Co., Ltd. in Pangen Co., Ltd. through a third-party capital increase. This document type is specifically used to notify the market of significant changes in share ownership levels, which aligns with the 'Major Shareholding Notification' category.
2021-06-14 Korean
증권발행결과(자율공시)
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from the Korean Exchange (KRX) titled '증권 발행결과' (Securities Issuance Results). It details the completion of a third-party capital increase (유상증자), including the number of shares issued, the amount raised, and the payment date. This falls under the category of share issuance and capital changes.
2021-06-11 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.